GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
0.2947
-0.0092 (-3.03%)
Jul 28, 2026, 11:46 AM EDT - Market open
GlucoTrack Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
15
Market Cap
1.84M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | 208.00K | 164.51K | 378.29% |
| Dec 31, 2018 | 43.49K | -545.97K | -92.62% |
| Dec 31, 2017 | 589.46K | -22.23K | -3.63% |
| Dec 31, 2016 | 611.69K | 468.52K | 327.26% |
| Dec 31, 2015 | 143.17K | 83.39K | 139.51% |
| Dec 31, 2014 | 59.78K | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Harvard Bioscience | 85.53M |
| Retractable Technologies | 37.15M |
| Bionano Genomics | 28.74M |
| Jin Medical International | 20.69M |
| Nephros | 19.12M |
| NEXGEL | 11.27M |
| Milestone Scientific | 8.90M |
| Lucyd | 2.98M |
GCTK News
- 10 days ago - E.F. Hutton & Co. Serves as Exclusive Financial Advisor on Strategic Business Combination Between Glucotrack and Lōkahi Therapeutics and Exclusive Placement Agent for Approximately $5.7 Million Convertible Note Financing - GlobeNewsWire
- 11 days ago - Glucotrack, Inc. and Lōkahi Therapeutics™ Announce Strategic Financing Support from E.F. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Initiatives - GlobeNewsWire
- 11 days ago - GlucoTrack Proxy statement: Proxy filing - Filings
- 11 days ago - UPDATE – Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform - GlobeNewsWire
- 13 days ago - Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform - GlobeNewsWire
- 20 days ago - GlucoTrack announces USPTO notice of allowance for patent application - TheFly
- 20 days ago - Glucotrack Announces USPTO Notice of Allowance for Patent Application Covering Its Implantable CBGM Platform - GlobeNewsWire
- 5 weeks ago - GlucoTrack Proxy statement: Proxy filing - Filings